CRC (Colorectal Cancer)
31
18
19
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
3.2%
1 terminated out of 31 trials
66.7%
-19.8% vs benchmark
3%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (31)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer
Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma
A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Size
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer
SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer
A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritoneal Metastasis of Colorectal Cancer
Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors